跳至主要内容
临床试验/EUCTR2006-006181-42-NL
EUCTR2006-006181-42-NL进行中(未招募)不适用

The use of USPIO enhanced MRI in the assessment of axillary lymph node status in patients with invasive breast cancer - The USPALS trial

MC St Radboud0 个研究点目标入组 440 人开始时间: 2006年12月1日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
440

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • nclusion criteria
  • - Histologically proven invasive breast cancer
  • - Surgical removal of at least 1 axillary lymph node will be performed
  • - Patient must be accessible for treatment
  • - Patient must provide written informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Exclusion criteria
  • - Patient age under 18
  • - Karnofsky score equal to or under 70
  • - Pregnant or lactating women
  • - Patients with conta-indications for MRI scanning (e.g. pacemaker, claustrophobia, ferromagnetic objects in the eyes or brain)
  • - Patients with contra-indications for the use of USPIO based contrast agents or dextran (e.g. known allergy)
  • - Male gender

研究者

发起方
MC St Radboud

相似试验